Skip to main content
. Author manuscript; available in PMC: 2015 Mar 9.
Published in final edited form as: Cancer Gene Ther. 2014 May 30;21(6):228–237. doi: 10.1038/cgt.2014.22

Table 1.

Anti-HAdv5 antibody in sera from tumor bearing hamsters treated with adenoviral vectors

Serum (HPT11) Serological test Serum (HPT 12) Serological test
Subcutaneous tumors
Vehicle - Vehicle 40
Ip11w 720 Ip11w 180
Ip11w/Δ55K 960 Ip11w/Δ55K 240
Ad5 wt 1280
Pouch tumors
Vehicle - Vehicle -
Ip11w 480 Ip11w 1440
Ip11w/Δ55K 640 Ip11w/Δ55K 640

Neutralizing antibody titers are expressed as the highest reciprocal serum dilutions. Average antibody titers from two animals from each group are presented. Hyper immunized serum raised against HAdV5 wt virus from hamster was used for positive control.